214 related articles for article (PubMed ID: 16024799)
1. ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.
Pedeux R; Sengupta S; Shen JC; Demidov ON; Saito S; Onogi H; Kumamoto K; Wincovitch S; Garfield SH; McMenamin M; Nagashima M; Grossman SR; Appella E; Harris CC
Mol Cell Biol; 2005 Aug; 25(15):6639-48. PubMed ID: 16024799
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of ING2 regulates the transcription mediated by Sin3A.
Ythier D; Larrieu D; Binet R; Binda O; Brambilla C; Gazzeri S; Pedeux R
Oncogene; 2010 Nov; 29(44):5946-56. PubMed ID: 20676127
[TBL] [Abstract][Full Text] [Related]
3. Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis.
Wang Y; Wang J; Li G
FEBS Lett; 2006 Jul; 580(16):3787-93. PubMed ID: 16782091
[TBL] [Abstract][Full Text] [Related]
4. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
[TBL] [Abstract][Full Text] [Related]
5. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
6. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
Kumamoto K; Spillare EA; Fujita K; Horikawa I; Yamashita T; Appella E; Nagashima M; Takenoshita S; Yokota J; Harris CC
Cancer Res; 2008 May; 68(9):3193-203. PubMed ID: 18451145
[TBL] [Abstract][Full Text] [Related]
7. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
8. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
9. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
[TBL] [Abstract][Full Text] [Related]
10. MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.
Sun G; Jin S; Baskaran R
Exp Cell Res; 2009 Nov; 315(18):3163-75. PubMed ID: 19766113
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles of p53 and p66shc during oxidative stress-induced senescence in fetal bovine fibroblasts.
Favetta LA; Robert C; King WA; Betts DH
Exp Cell Res; 2004 Sep; 299(1):36-48. PubMed ID: 15302571
[TBL] [Abstract][Full Text] [Related]
12. p53 targets simian virus 40 large T antigen for acetylation by CBP.
Poulin DL; Kung AL; DeCaprio JA
J Virol; 2004 Aug; 78(15):8245-53. PubMed ID: 15254196
[TBL] [Abstract][Full Text] [Related]
13. DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.
Nagashima M; Shiseki M; Miura K; Hagiwara K; Linke SP; Pedeux R; Wang XW; Yokota J; Riabowol K; Harris CC
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9671-6. PubMed ID: 11481424
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of growth 2 regulates the high glucose-induced cell cycle arrest and epithelial-to-mesenchymal transition in renal proximal tubular cells.
Ma Y; Yan R; Wan Q; Lv B; Yang Y; Lv T; Xin W
J Physiol Biochem; 2020 Aug; 76(3):373-382. PubMed ID: 32424454
[TBL] [Abstract][Full Text] [Related]
15. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence.
Miyajima C; Kawarada Y; Inoue Y; Suzuki C; Mitamura K; Morishita D; Ohoka N; Imamura T; Hayashi H
Cells; 2020 Jan; 9(1):. PubMed ID: 31936650
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of p53 serine 15 increases interaction with CBP.
Lambert PF; Kashanchi F; Radonovich MF; Shiekhattar R; Brady JN
J Biol Chem; 1998 Dec; 273(49):33048-53. PubMed ID: 9830059
[TBL] [Abstract][Full Text] [Related]
18. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
19. ING2 controls the G1 to S-phase transition by regulating p21 expression.
Larrieu D; Ythier D; Brambilla C; Pedeux R
Cell Cycle; 2010 Oct; 9(19):3984-90. PubMed ID: 20890119
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas.
Saito M; Kumamoto K; Robles AI; Horikawa I; Furusato B; Okamura S; Goto A; Yamashita T; Nagashima M; Lee TL; Baxendale VJ; Rennert OM; Takenoshita S; Yokota J; Sesterhenn IA; Trivers GE; Hussain SP; Harris CC
PLoS One; 2010 Nov; 5(11):e15541. PubMed ID: 21124965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
